NUEZZO
Live / Allowed — Published for opposition (as of 24 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99371968
- Mark type
- Stylized text
- Filed
- 03 Sept 2025
- Published for opposition
- 24 Feb 2026
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Feb 2026 — PUBLISHED FOR OPPOSITION
- 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jan 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 16 Jan 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 16 Jan 2026 — LETTER OF SUSPENSION E-MAILED
- 16 Jan 2026 — SUSPENSION LETTER WRITTEN
- 16 Jan 2026 — ASSIGNED TO EXAMINER
- 03 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 03 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Sept 2025 — NEW APPLICATION ENTERED